ABOUT US

Evozyne designs novel protein therapeutics to solve previously unaddressable patient needs. AI allows us to operate at a scale and speed never before possible.

These therapeutics have a higher probability of success because of Evozyne’s iterative approach to drug discovery and development. The sequence-to-function protein design process delivers novel molecules that perform to functional standards. Each protein created is rapidly improved through design/build/test rounds in our wet and dry labs, increasing the speed and quality of the discovery process while reducing costs.